Imnovid® 4 mg


Hard capsule
scheduling status
S4
registration number
49/32.2/0747
What Imnovid® 4 mg contains
Pomalidomide.
other ingredients
Mannitol, pregelatinised starch, sodium stearyl fumarate and a gelatin capsule shell. Capsule shell: 4 mg capsule shell contains gelatin, titanium dioxide (E171), indigotine (E132), brilliant blue FCF (E133) and white ink. Printing ink: 4 mg capsule shell contains: white ink – shellac, titanium dioxide (E171), simethicone, propylene glycol (E1520) and ammonium hydroxide (E527).
Therapeutic classification
L04AX06.
© 2026 SAHPRA. ALL RIGHTS RESERVED